Rakuten Medical is a biotechnology company that strives to develop cancer treatments. Their approach involves the use of cell-targeting therapies that are administered through the company’s proprietary Alluminox platform. Rakuten Medical was founded in 2010 and is headquartered in San Diego, CA. The platform is based on a cancer therapy called photoimmunotherapy, which was developed by Dr. Hisataka Kobayashi and the team at the U.S.-based National Cancer Institute. The global company focuses on the development and commercialization of its precision-based therapies designed to treat a variety of cancers.
Rakuten Medical is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Rakuten Medical pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Rakuten Medical is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
---|---|---|---|---|
8/18/2023 | Series E, E-1, E-2 and E-3 | $104.82MM raised | $XXX.XX | $XXX.XX |
7/28/2021 | Series D | $166MM raised | $XXX.XX | $XXX.XX |
12/31/2020 | Series C-2 | $15MM raised | $XXX.XX | $XXX.XX |
7/31/2019 | Series C-1 | $100.79MM raised | $XXX.XX | $XXX.XX |
12/21/2018 | Series C | $284.69MM raised | $XXX.XX | $XXX.XX |
9/12/2017 | Series B-1 | $19MM raised | $XXX.XX | $XXX.XX |
10/5/2016 | Series B | $56.12MM raised | $XXX.XX | $XXX.XX |
7/30/2015 | Series A | $14.32MM raised | $XXX.XX | $XXX.XX |